In a report issued on July 24, Joy Zhang CFA from SVB Securities reiterated a Buy rating on IQVIA Holdings (IQV – Research Report), with a price target of $256.00. The company’s shares closed last Tuesday at $219.68.
According to TipRanks.com, CFA is a 2-star analyst with an average return of 0.1% and a 50.0% success rate. CFA covers the Technology sector, focusing on stocks such as Computer Programs and Systems, Hims & Hers Health, and OptimizeRx.
Currently, the analyst consensus on IQVIA Holdings is a Strong Buy with an average price target of $264.07, a 19.3% upside from current levels. In a report issued on July 11, Jefferies also maintained a Buy rating on the stock with a $255.00 price target.
Based on IQVIA Holdings’ latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $3.54 billion and net profit of $256 million. In comparison, last year the company earned revenue of $3.44 billion and had a net profit of $175 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
North Carolina-based IQVIA Holdings, Inc. provides advanced analytics, technology solutions, and contract research services to the life sciences industry. The company operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.
Read More on IQV:
- Mizuho Securities Keeps a Buy Rating on Tenet Healthcare (THC)
- Sensient Technologies (SXT) Receives a Hold from Robert W. Baird
- Mizuho Securities Keeps a Hold Rating on Range Resources (RRC)
- PPG Industries (PPG) Gets a Buy Rating from Robert W. Baird
- Fleetcor Technologies (FLT) Gets a Hold Rating from Robert W. Baird